These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31084789)

  • 1. Ultrasound assisted crystallization of a new cardioactive prototype using ionic liquid as solvent.
    Resende de Azevedo J; Espitalier F; Ré MI
    Ultrason Sonochem; 2019 Jul; 55():32-43. PubMed ID: 31084789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolution enhancement of Deflazacort using hollow crystals prepared by antisolvent crystallization process.
    Paulino AS; Rauber G; Campos CE; Maurício MH; de Avillez RR; Capobianco G; Cardoso SG; Cuffini SL
    Eur J Pharm Sci; 2013 May; 49(2):294-301. PubMed ID: 23557843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-assisted solution crystallization of fotagliptin benzoate: Process intensification and crystal product optimization.
    Fang L; Gao Z; Wu S; Jia S; Wang J; Rohani S; Gong J
    Ultrason Sonochem; 2021 Aug; 76():105634. PubMed ID: 34218067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H.
    Zu Y; Li N; Zhao X; Li Y; Ge Y; Wang W; Wang K; Liu Y
    Int J Pharm; 2014 Apr; 464(1-2):1-9. PubMed ID: 24456674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
    Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
    Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisolvent membrane crystallization of pharmaceutical compounds.
    Di Profio G; Stabile C; Caridi A; Curcio E; Drioli E
    J Pharm Sci; 2009 Dec; 98(12):4902-13. PubMed ID: 19655372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid anti-solvent recrystallization to enhance dissolution of CRS 74, a new antiretroviral drug.
    de Paiva Lacerda S; Espitalier F; Hoffart V; Ré MI
    Drug Dev Ind Pharm; 2015; 41(11):1910-20. PubMed ID: 25792230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs.
    Dong Y; Ng WK; Hu J; Shen S; Tan RB
    Int J Pharm; 2010 Feb; 386(1-2):256-61. PubMed ID: 19922777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique.
    Maghsoodi M; Taghizadeh O; Martin GP; Nokhodchi A
    Int J Pharm; 2008 Mar; 351(1-2):45-54. PubMed ID: 17980983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissolution enhancement of gliclazide using ultrasound waves and stabilizers in liquid anti-solvent precipitation.
    Al-Nimry SS; Qandil AM; Salem MS
    Pharmazie; 2014 Dec; 69(12):874-80. PubMed ID: 25951659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous synthesis of polymer-coated drug particles by porous hollow fiber membrane-based antisolvent crystallization.
    Chen D; Singh D; Sirkar KK; Pfeffer R
    Langmuir; 2015; 31(1):432-41. PubMed ID: 25552289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of binder liquid type on spherical crystallization.
    Maghsoodi M; Hajipour A
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1468-75. PubMed ID: 23937581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mathematical model to analyze the dissolution behavior of metastable crystals or amorphous drug accompanied with a solid-liquid interface reaction.
    Hirai D; Iwao Y; Kimura SI; Noguchi S; Itai S
    Int J Pharm; 2017 Apr; 522(1-2):58-65. PubMed ID: 28235625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled antisolvent precipitation of spironolactone nanoparticles by impingement mixing.
    Dong Y; Ng WK; Shen S; Kim S; Tan RB
    Int J Pharm; 2011 May; 410(1-2):175-9. PubMed ID: 21397674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
    Usha AN; Mutalik S; Reddy MS; Ranjith AK; Kushtagi P; Udupa N
    Eur J Pharm Biopharm; 2008 Oct; 70(2):674-83. PubMed ID: 18606224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of solvents in improvement of dissolution rate of drugs: crystal habit and crystal agglomeration.
    Maghsoodi M
    Adv Pharm Bull; 2015 Mar; 5(1):13-8. PubMed ID: 25789214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-drying.
    de Waard H; Hinrichs WL; Frijlink HW
    J Control Release; 2008 Jun; 128(2):179-83. PubMed ID: 18423767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of mixing and ultrasound frequency on antisolvent crystallisation of sodium chloride.
    Lee J; Ashokkumar M; Kentish SE
    Ultrason Sonochem; 2014 Jan; 21(1):60-8. PubMed ID: 23948494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization.
    Maghsoodi M; Tajalli Bakhsh AS
    Pharm Dev Technol; 2011 Jun; 16(3):243-9. PubMed ID: 20175665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.